Skip to main content

Guidelines

The RCOG produces guidelines as an aid to good clinical practice. Our guidelines present recognised methods and techniques for clinical practice, based on published evidence, for consideration by obstetricians/gynaecologists and other relevant health professionals. Find out more about the different types of guideline we publish.

All guidelines on this website are current and remain so until replaced. Find out how to access previous versions of guidelines.

You can browse all of our guidelines below, or search for guidelines by type, by subject or by keyword.

We also publish a range of patient information leaflets.

Search for a guideline

By guideline type

By keyword


Sort results

























Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) (Scientific Impact Paper No. 61)
This Scientific Impact Paper considers the latest evidence in relation to treatment options in the prenatal management of pregnancies at risk of FNAIT; specifically, the role of screening, immunoglobulins, steroids, fetal blood sampling and intrauterine platelet transfusion.
Published 10/04/2019
Valproate Use In Women and Girls Of Childbearing Years
Guidance for doctors and other healthcare professionals regarding the use of sodium valproate.
Published 29/03/2019
The Combined Use of Ultrasound and Fetal Magnetic Resonance Imaging for a Comprehensive Fetal Neurological Assessment in Fetal Congenital Cardiac Defects (Scientific Impact Paper No. 60)
This Scientific Impact Paper summarises the available evidence for the combined use of ultrasound and fetal magnetic resonance imaging to comprehensively assess the brain in fetuses with congenital cardiac defects.
Published 27/03/2019
Clinical Guidelines for Early Medical Abortion at Home – England
This document provides guidance for healthcare professionals in England who provide care for women considering early medical abortion at home (EMA) up to and including 9 weeks 6 days gestation when the first medication is administered.
Published 03/01/2019
Antenatal and Postnatal Analgesia (Scientific Impact Paper No. 59)
The purpose of this Scientific Impact Paper is to clarify advice regarding pain relief in the antenatal and postnatal periods reviewing evidence from the Medicines and Healthcare products Regulatory Agency and European Medicines Agency.
Published 13/12/2018
Care of Women with Obesity in Pregnancy (Green-top Guideline No. 72)
This guideline covers interventions prior to conception, and during and after pregnancy when caring for women with obesity.
Published 22/11/2018
Diagnostic Biomarkers for Predicting Adverse Early Pregnancy Outcomes (Scientific Impact Paper No. 58)
This Scientific Impact Paper discusses the controversies surrounding the current use of biomarkers and their potential future use.
Published 07/11/2018
Vasa Praevia: Diagnosis and Management (Green-top Guideline 27b)
This guideline describes the diagnostic modalities and reviews the evidence-based approach to the clinical management of pregnancies complicated by vasa praevia.
Published 27/09/2018
Placenta Praevia and Placenta Accreta: Diagnosis and Management (Green-top Guideline No. 27a)
This guideline describes the diagnostic modalities and reviews the evidence-based approach to the clinical management of pregnancies complicated by placenta praevia and placenta accreta.
Published 27/09/2018
Epigenetics and Reproductive Medicine (Scientific Impact Paper No. 57)
This Scientific Impact Paper summarises current viewpoints on our understanding of epigenetics and the relevance of these findings to reproductive medicine.
Published 25/09/2018